Biodegradablè poly (lactic acid) microspheres for drug delivery systems

Yonsei Medical Journal

Volumn 41, Issue 6, 2000, Pages 720-734

  Hyon, S H ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Biodegradable polymers; Controlled drug release

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; COPOLYMER; DOXORUBICIN; FLUOROURACIL; MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; LACTIC ACID;

BIODEGRADATION; CONTROLLED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INDUCED DISEASE; GASTROINTESTINAL CARCINOMA; HUMAN; MICROCAPSULE; PLEURA CANCER; REVIEW; ANIMAL; ARTIFICIAL SKIN; BIOREMEDIATION;

ANIMALS; BIODEGRADATION, ENVIRONMENTAL; DRUG DELIVERY SYSTEMS; HUMANS; LACTIC ACID; MICROSPHERES; POLYMERS; SKIN, ARTIFICIAL;

EID: 0034352022     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2000.41.6.720     Document Type: Review

References (57)

1. Chemical and physical structure of polymers as carriers for controlled release of bioactive agents: A review
2. Effects of the residual monomer on the degradation of DL-Lactide polymer
3. Dergradation of high molecular weight poly (L-lactide) in alkaline medium
4. Polylactic acid for surgical implants
5. Biodegradation of and tissue reaction to 50 : 50 Poly (DL-lactide-co-glycolide) microcapsules
6. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches
7. Long-term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders
8. Characterization of drug-loaded poly (d,I-lactide) microspheres
9. Clinical evaluation of an improved injectable microcapsule contraceptive system
10. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics
11. A physicochemical study of the morphology of progesterone-loaded poly (D,L-lactide) microspheres
12. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique
13. 2 from polylactic acid microcapsules, microparticles and modified microparticles
14. A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading
15. Microencapsulation using poly (L-lactic acid) I? Microcapsule properties affected by the preparative technique
16. Biodegradable microspheres: Vaccine delivery system for oral immunization
17. Biodegradable and biocompatible poly (DL-Lactide-Co-Glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies
18. Controlled vaccine release in release in the gut-associated lymphoid tissue. 1. Orally administered biodegradable microspheres target the Peyer's patches
19. Biodegradable microspheres as a vaccine delivery system
20. Non-inflammatory peptide fragments of IL 1 as safe new-generation adjuvants
21. Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide
22. Synthesis of polylactides with different molecular weights
23. Lewis acid catalyzed polymerization of L-lactide. Kinetics and mechanism of the bulk polymerization
24. Polym. Science, Polym. "New high-yield, one-step synthesis of polyglycolide from haloacetic acid"
25. Uber hochmolekulare, inshesondere optisch active polyester der Milch sure, ein Beitrag zur Stereochemie makromolekularer Verbindungen
26. Polymerizable esters of lactic acid
27. Condensation of glycolic, lactic and 2-hydroxybutanoic acid during heating and identification of the condensation products by GLC-MC
28. Biodegradable polymers for use in surgery-polyglycolic/poly (lactic acid) homo- and co-polymers; 1."
29. Lactic acid oligomer microspheres containing an anticancer agent for selective lymphatic delivery: I. In Vitro Studies
30. Targeted and sustained delivery of aclarubicin to lymphatics by lactic acid-oligomer microsphere in rat
31. A sensitive analytical method for aclacinomycin a and its analogs by thin-layer chromatography and fluorescence scanning
32. Biodegradation of biomedical polymers
33. Preparation of biodesradable microspheres and microcapsules: 2. Polylactides and related polyesters
34. A new long-acting injectable microcapsule system for the administration of progesterone
35. Evaluation of aclacinomycin-A in patients with head and neck cancer
36. Lactic acid oligomer microspheres containing hydrophilic drugs
37. A physicochemical study of the morphology of progesterone-loaded poly (D, L-Lactide) microspheres
38. A new long-acting injectable microcapsule system for the administration of progesterone
39. Biodegradation and antitumour effects of adriamycin-containing Poly (L-lactic acid) microspheres
40. "Release and degradation characteristics and antitumour effect of adriamycin-containing poly-L-lactic acid microspheres" implant materials in biofunction
41. Preparation of lactic acid oligomer microspheres containing anticancer drug by O/O type solvent evaporation process
42. Preparation of poly (lactic acid) microspheres containing anti-cancer drugs
43. Biodegradations and in vivo effects of biodegradable polymers (4)
44. A bilayer "artificial skin" capable of sustained release of an antibiotic
45. Evaluation of a bilayer artifial skin capable of sustained release of an antibiotic
46. Intraperitoneal administration of 5-fluorouracil microspheres against peritoneal carcinomatosis in rodents
47. Therapeutic effects of 5-flurouracil microspheres on peritoneal carcinomatosis induced by colon 26 or B-16 melanoma in mice
48. Phase I and pharmacological studies of 5-flurouracil administered intraperitoneally
49. Filtration and absorption through serous membranes
50. Kinetic analysis of 5-fluorouracil action against various cancer cells
51. Cisplatin-releasing bioresorbable microspheres for the treatment of malignant pleural effusion
52. Concentrations of cisplatin in serum and in effusion after administration of cisplatin-releasing bioresorbable microspheres for patients with malignant pleural effusions
53. Biodegradation and antitumour effect of adriamycin-containing poly (L-lactide acid) microspheres
54. Effect of preparation condition of cisplatin-loaded microspheres on the in vitro release
55. In vivo suppressive effects of copoly (glycolic/ L-lactide acid) microspheres containing CDDP on murine tumor cells
56. Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents
57. Controlled cisplatin delivery system using poly (D, L-lactid)